miR-4306 Suppresses Proliferation of Esophageal Squamous Cell Carcinoma Cell by Targeting SIX3

被引:10
|
作者
Yang, Chengyuan [1 ]
Guo, Zichan [1 ]
Zhao, Zitong [2 ]
Wei, Yuan [1 ]
Wang, Xiaoxia [1 ]
Song, Yongmei [2 ]
机构
[1] Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan 030001, Shanxi, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, State Key Lab Mol Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China
基金
中国国家自然科学基金;
关键词
miR-4306; Esophageal squamous cell carcinoma; SIX3; proliferation; Invasion; THERAPEUTIC TARGET; METASTASIS;
D O I
10.1007/s12013-021-00994-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive cancers and the primary cause of cancer-related mortality in China. micoRNA plays a vital role during tumor initiation and malignant progression. miR-4306 has been reported to negatively regulate aggressive cell phenotypes in triple-negative breast cancer (TNBC). Nevertheless, the function of miR-4306 in ESCC was still not clear. In this study, we detected miR-4306 expression by quantitative real-time reverse transcription-PCR (qRT-PCR) and found that miR-4306 expression was downregulated in human ESCC tissue samples and cell lines. Moreover, miR-4306 overexpression could restrain ESCC cell proliferation, migratory and invasive ability and epithelial-mesenchymal transition (EMT), promote cell apoptosis after treatment with or without cisplatin. In contrast, inhibiting the expression of miR-4306 showed the opposing results. Furthermore, we explored the molecular mechanism of effects of miR-4306 and found that miR-4306 inhibited the expression of SIX3 by interaction with SIX3 3 ' UTR in ESCC cells, and SIX3 overexpression significantly reversed the effect of miR-4306-mediated ESCC cells proliferation. The current study provided evidence of miR-4306 as a tumor suppression gene in ESCC.
引用
收藏
页码:769 / 779
页数:11
相关论文
共 50 条
  • [41] MiR-143-3p suppresses cell proliferation, migration, and invasion by targeting Melanoma-Associated Antigen A9 in laryngeal squamous cell carcinoma
    Han, Liang
    Tang, Mingming
    Xu, Xinjiang
    Jiang, Bin
    Wei, Yingze
    Qian, Hongyan
    Lu, Xueguan
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (02) : 1245 - 1257
  • [42] Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A
    Zhuo Bao
    Ang Li
    Xuebo Lu
    Zitong Wang
    Yin Yu
    Wenjie Wu
    Lili Zhao
    Bo Li
    Xiangyu Wu
    Kyle Vaughn Laster
    Chengjuan Zhang
    Yanan Jiang
    Zigang Dong
    Kangdong Liu
    Cell Death & Disease, 13
  • [43] Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A
    Bao, Zhuo
    Li, Ang
    Lu, Xuebo
    Wang, Zitong
    Yu, Yin
    Wu, Wenjie
    Zhao, Lili
    Li, Bo
    Wu, Xiangyu
    Laster, Kyle Vaughn
    Zhang, Chengjuan
    Jiang, Yanan
    Dong, Zigang
    Liu, Kangdong
    CELL DEATH & DISEASE, 2022, 13 (02)
  • [44] Silencing of miR-17-5p suppresses cell proliferation and promotes cell apoptosis by directly targeting PIK3R1 in laryngeal squamous cell carcinoma
    Wang, Jian-Xing
    Jia, Xin-Ju
    Liu, Yan
    Dong, Jin-Hui
    Ren, Xiu-Min
    Xu, Ou
    Liu, Sheng-Hui
    Shan, Chun-Guang
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [45] Silencing of miR-17-5p suppresses cell proliferation and promotes cell apoptosis by directly targeting PIK3R1 in laryngeal squamous cell carcinoma
    Jian-Xing Wang
    Xin-Ju Jia
    Yan Liu
    Jin-Hui Dong
    Xiu-Min Ren
    Ou Xu
    Sheng-Hui Liu
    Chun-Guang Shan
    Cancer Cell International, 20
  • [46] miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1
    Xu, Ran
    Zeng, Guang
    Gao, Jing
    Ren, Yue
    Zhang, Zhe
    Zhang, Qingna
    Zhao, Jinxiu
    Tao, Hong
    Li, Daxu
    ONCOLOGY REPORTS, 2015, 34 (04) : 2171 - 2178
  • [47] Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma
    Yubing Zhou
    Xinyu He
    Yanan Jiang
    Zitong Wang
    Yin Yu
    Wenjie Wu
    Chenyang Zhang
    Jincheng Li
    Yaping Guo
    Xinhuan Chen
    Zhicai Liu
    Jimin Zhao
    Kangdong Liu
    Zigang Dong
    Frontiers of Medicine, 2023, 17 (02) : 290 - 303
  • [48] Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma
    Zhou, Yubing
    He, Xinyu
    Jiang, Yanan
    Wang, Zitong
    Yu, Yin
    Wu, Wenjie
    Zhang, Chenyang
    Li, Jincheng
    Guo, Yaping
    Chen, Xinhuan
    Liu, Zhicai
    Zhao, Jimin
    Liu, Kangdong
    Dong, Zigang
    FRONTIERS OF MEDICINE, 2023, 17 (02) : 290 - 303
  • [49] Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma
    Yubing Zhou
    Xinyu He
    Yanan Jiang
    Zitong Wang
    Yin Yu
    Wenjie Wu
    Chenyang Zhang
    Jincheng Li
    Yaping Guo
    Xinhuan Chen
    Zhicai Liu
    Jimin Zhao
    Kangdong Liu
    Zigang Dong
    Frontiers of Medicine, 2023, 17 : 290 - 303
  • [50] MiR-143 inhibits tumour progression by targeting STAT3 in esophageal squamous cell carcinoma
    Li, B.
    Liu, S. C. H. Et. I. Jia
    Mao, S. C. H. Et. I. Yu
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S479 - S479